Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes.

Source:http://linkedlifedata.com/resource/pubmed/id/11887170

Download in:

View as

General Info

PMID
11887170